NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
1.970
-0.030 (-1.50%)
At close: Jul 10, 2026, 4:00 PM EDT
1.980
+0.010 (0.51%)
After-hours: Jul 10, 2026, 6:12 PM EDT
NextCure Market Cap
NextCure has a market cap or net worth of $7.12 million as of July 10, 2026. Its market cap has decreased by -45.57% in one year.
Market Cap
7.12M
Enterprise Value
-17.71M
1-Year Change
-45.57%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $7.12M, a decrease of -98.37%. That is a compound annual growth rate of -43.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 7.12M | -85.70% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kairos Pharma | 7.92M |
| Aspire Biopharma Holdings | 7.86M |
| CNS Pharmaceuticals | 7.77M |
| Bolt Biotherapeutics | 7.65M |
| PharmaCyte Biotech | 7.51M |
| Can-Fite BioPharma | 7.31M |
| Ernexa Therapeutics | 6.92M |
| Pulmatrix | 6.57M |